IDEAYA Biosciences, Inc. IDYA Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s change in accrued liabilities?
- IDEAYA Biosciences, Inc. (IDYA) reported change in accrued liabilities of $2.73M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s change in accrued liabilities changed year-over-year?
- IDEAYA Biosciences, Inc.'s change in accrued liabilities decreased by 5.1% year-over-year, from $2.88M to $2.73M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s change in accrued liabilities?
- Over 3 years (2021 to 2024), IDEAYA Biosciences, Inc.'s change in accrued liabilities has grown at a 36.8% compound annual growth rate (CAGR), from $4.21M to $10.79M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.